Kevin N. Dalby

Dr. Dalby is Johnson & Johnson Centennial Professor of Medicinal Chemistry at UT Austin, a distinguished medicinal chemist and enzymologist who is the Co-PI of the GCC HTS Program and its MIRA (RP110532). Dr. Dalby is the author of more than 85 publications on the molecular basis of protein kinase regulation and cancer-related drug discovery research. Dr. Dalby directs the medicinal chemistry & biochemistry, as well as the overall operations of the TTDDDP.